Showing results (101-110 of 252) with videos related to
Sort By:
Pageof 26
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 25, 2003
Interactive role of adenosine and dopamine in the opiate withdrawal syndromeLuigi Stella, Vito De Novellis, Maria Redenta Vitelli, et al.Expert Opinion on Investigational Drugs|March 29, 2014
Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancerMorena Fasano, Carminia Maria Della Corte, Raffaele Califano, et al.Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance DatabaseRosanna Ruggiero, Annamaria Mascolo, Angela Spezzaferri, et al.Frontiers in Immunology|October 20, 2022
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax studyAnnamaria Mascolo, Gabriella di Mauro, Federica Fraenza, et al.Pharmacological Research|July 12, 2017
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reportingAnnamaria Mascolo, Cristina Scavone, Maurizio Sessa, et al.Cancers|March 13, 2024
Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic ReviewSara Mucherino, Valentina Lorenzoni, Isotta Triulzi, et al.Pharmacological Reports : PR|May 28, 2026
Evaluation of the safety profile of glucagon-like peptide-1 receptor agonists: a focus on thyroid cancer-related adverse events by using the European pharmacovigilance databaseAntonietta Anatriello, Valerio Liguori, Ciro Pentella, et al.British Journal of Pharmacology|November 22, 2005
Inflammatory events in a vascular remodeling model induced by surgical injury to the rat carotid arteryBarbara Rinaldi, Paolo Romagnoli, Stefano Bacci, et al.BMJ Open|September 9, 2021
Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: a systematic review protocolSara Mucherino, Valentina Lorenzoni, Valentina Orlando, et al.Drugs - Real World Outcomes|December 19, 2019
Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern ItalyCristina Scavone, Cristina Di Mauro, Rosanna Ruggiero, et al.Pageof 26